" /> FDA approves Roche's Cotellic for combination skin cancer therapy | DietarySupplement.com

BACK TO TOP

128

FDA approves Roche's Cotellic for combination skin cancer therapy

DietarySupplements (#1) 1345 days ago Health fda approves roches cotellic combination skin cancer therapy All http://feeds.reuters.com   Discuss  | Add To 
ZURICH (Reuters) - The U.S. Food and Drug Administration on Tuesday approved Swiss drugmaker Roche's Cotellic to be used in combination with the company's Zelboraf drug to treat BRAF V600 mutation-positive advanced melanoma.













Advertise With Us!

Dietary Supplement & Health Search Engine

Dietary Supplement Reviews from users worldwide. Get up to date dietary supplement information from name brand dietary supplement makers at DietarySupplement.com








Featured Supplements

Advertise With Us!